Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 30,613 shares at $12.61 ($386K) on 2022-08-16, disclosed to the SEC on 2022-08-17.
Open-market sale of $386k RXRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.96 | 613 | $8K | 2.1% |
| 2 | $12.61 | 30,000 | $378K | 97.9% |
| Total | $12.62 avg | 30,613 | $386K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |